HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,697,280 | -23.5% | 234,888 | -17.9% | 0.05% | -20.7% |
Q2 2023 | $10,065,185 | -18.1% | 286,024 | -24.0% | 0.06% | -22.7% |
Q1 2023 | $12,289,003 | -41.2% | 376,386 | -0.7% | 0.08% | -46.8% |
Q4 2022 | $20,884,388 | +12.0% | 379,027 | -10.0% | 0.14% | -4.1% |
Q3 2022 | $18,653,000 | – | 421,165 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |